Phenotypic screening converges on CDK9 inhibition as a therapeutic strategy in translocation renal cell carcinoma
Dharma R. Thapa(University of California, Los Angeles), Srinivas R. Viswanathan(Dana-Farber Cancer Institute)
Cited by 1
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
|Nature Communications|2021|167
Integrative clinical and molecular characterization of translocation renal cell carcinoma
|Cell Reports|2022|115
TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism
|Nature Communications|2021|102